ACADIA PHARMACEUTICALS INC (ACAD)

US0042251084 - Common Stock

16.66  -0.29 (-1.71%)

Buy % Consensus

77

ChartMill assigns a Buy % Consensus number of 77% to ACAD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 25.61. This target is 53.71% above the current price.
ACAD was analyzed by 26 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ACAD.
In the previous month the buy percentage consensus was at a similar level.
ACAD was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 16.6611.1126.5225.6140.95 - -33.31% 59.18% 53.71% 145.80%
Up and Down Grades
Date Firm Action Rating
2024-11-07 Needham Reiterate Buy -> Buy
2024-11-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-10 Raymond James Reiterate Market Perform
2024-08-08 UBS Maintains Buy -> Buy
2024-08-08 Citigroup Maintains Buy -> Buy
2024-08-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-07 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-08-07 Needham Maintains Buy -> Buy
2024-08-07 RBC Capital Maintains Outperform -> Outperform
2024-08-07 Morgan Stanley Downgrade Overweight -> Equal-Weight
2024-07-12 Morgan Stanley Maintains Overweight -> Overweight
2024-06-27 BMO Capital Initiate Outperform
2024-06-25 RBC Capital Reiterate Outperform -> Outperform
2024-05-10 B of A Securities Maintains Neutral -> Neutral
2024-05-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-05-09 Mizuho Maintains Neutral -> Neutral
2024-05-09 Needham Reiterate Buy -> Buy
2024-05-09 Stifel Maintains Hold -> Hold
2024-05-09 Baird Maintains Outperform -> Outperform
2024-05-09 Citigroup Maintains Buy -> Buy
2024-05-09 HC Wainwright & Co. Maintains Buy -> Buy
2024-05-06 Oppenheimer Maintains Perform -> Perform
2024-04-30 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-10 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-09 Needham Reiterate Buy -> Buy
2024-03-25 JP Morgan Maintains Overweight -> Overweight
2024-03-13 Morgan Stanley Maintains Overweight -> Overweight
2024-03-12 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-03-12 Mizuho Downgrade Buy -> Neutral
2024-03-12 JMP Securities Maintains Outperform -> Outperform